Respiratory Tract Infections  >>  Alvesco (ciclesonide)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Alvesco (ciclesonide) / Covis Pharma, Teijin, Korea University Medical Center
SISRIP, NCT01369563: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

Completed
N/A
1630
RoW
AstraZeneca
Perennial Rhinitis, Seasonal Rhinitis
05/12
05/12

Download Options